|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:oxycodone
acetaminophen
|
|
gptkbp:approvedBy
|
1976
|
|
gptkbp:ATCCode
|
N02AA55
|
|
gptkbp:brand
|
oxycodone/acetaminophen combination
|
|
gptkbp:broadcastOn
|
gptkb:Schedule_II_(US)
|
|
gptkbp:contraindication
|
paralytic ileus
hypersensitivity to acetaminophen
hypersensitivity to oxycodone
severe asthma
|
|
gptkbp:controlledSubstanceAct
|
yes
|
|
gptkbp:drugInteraction
|
gptkb:beer
gptkb:MAO_inhibitors
gptkb:CNS_depressants
|
|
gptkbp:eliminatedIn
|
renal
hepatic
|
|
gptkbp:form
|
gptkb:tablet
10/325 mg
2.5/325 mg
5/325 mg
7.5/325 mg
|
|
gptkbp:genericAvailable
|
yes
|
|
gptkbp:halfLife
|
1-4 hours (acetaminophen)
3-4 hours (oxycodone)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Percocet
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Endo_Pharmaceuticals
|
|
gptkbp:marketedIn
|
gptkb:Canada
gptkb:United_States
|
|
gptkbp:notRecommendedFor
|
children under 12
|
|
gptkbp:overdoseTreatment
|
gptkb:naloxone
supportive care
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prescribes
|
severe pain
moderate pain
|
|
gptkbp:riskFactor
|
addiction
overdose
respiratory depression
liver damage
misuse
withdrawal symptoms
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
constipation
dizziness
drowsiness
|
|
gptkbp:usedFor
|
pain relief
|
|
gptkbp:bfsParent
|
gptkb:Percs
|
|
gptkbp:bfsLayer
|
6
|